Avoid Using the Abbreviation "tPA" for Alteplase

You'll hear controversy about whether more patients should receive alteplase (Activase) for acute ischemic stroke.

New labeling suggests broadening the scope of stroke patients who should get alteplase. But this is due to new rules designed to simplify labeling...not new evidence.

Now the Am Heart and Stroke Associations are weighing in...saying yes to using alteplase in more patients...but with a few cautions.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote